Amgen (AMGN)

86.77

+1.55 (+1.82%)

Range	85.39 - 87.165
52 week	65.37 - 90.81
Open	85.75
Vol/Avg.	5,005,710

Mkt cap	65.598B
P/E	15.44
EPS	5.52
Book/share	25.212

Short ratio	4.00
PEG	1.23
EPS est.	1.72

Rare webinar exposes 1 new law that will kill
your wealth in 2013 unless you take action now...

AMGN additional information

Loading ...

Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.

Trading Offers • Rare webinar exposes 1 new law that will kill your wealth in 2013 unless you take action now...		Special Offers • Download a free Options Fundamentals Podcast, from The Options Industry Council.

AMGN Profile

•

Exchange

NASDAQ

•

Sector

Healthcare

•

Industry

Biotechnology

•

Top Holders (By Fund)

Vanguard PRIMECAP Inv
Vanguard PRIMECAP Adm
American Funds Invmt Co of America 529E
American Funds Invmt Co of America B
American Funds Invmt Co of America 529F
American Funds Invmt Co of America A
American Funds Invmt Co of America 529C
American Funds Invmt Co of America 529B
American Funds Invmt Co of America 529A
American Funds Invmt Co of America C

•

Top Holders (By Family)

American Funds
Vanguard
Fidelity Investments
Legg Mason/Western
PowerShares
BlackRock
JPMorgan
iShares
State Street Global Advisors
Van Eck

•

Competitors

Johnson & Johnson
NPS Pharmaceuticals
Novartis AG
Teva Pharmaceutical Industries

•

Executives

Mr. Robert A. Bradway
Chief Exec. Officer
Pres Chief Operating Officer and Director
Mr. Jonathan M. Peacock
Chief Financial Officer and Exec. VP

Mr. Anthony C. Hooper
Exec. VP of Global Commercial Operations

Dr. Fabrizio J. Bonanni
Exec. VP

Mr. David W. Beier
Sr. VP

•

Index Membership

Nasdaq 100
NASDAQ Composite
NASDAQ Biotechnology

•

Employee Count

17,500